Digitisation | September 02, 2022
Infosys completes acquisition of BASE life science
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
Therapy recently approved in Canada under the brand name KORSUVA
Syngene's collaboration with Zoetis started in 2011
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
The Congress was held on June, 20-21, 2022 in Berlin, Germany
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
Subscribe To Our Newsletter & Stay Updated
